01—Abstract
Summary
Summary of the 10-Q filed September 19, 2012. Cited figures are marked; the original filing is the authoritative source.
Quture International, Inc. (BRRN) has filed its quarterly report for the period ending July 31, 2012.
The company is operating under substantial doubt regarding its ability to continue as a going concern, with significant operating losses, a working capital deficit, and a very low cash balance of $5,420a. While the company is developing medical software solutions, its revenue remains minimal, with $9,000 for the quarter, a decrease from $10,800 in the prior year. Operating expenses significantly increased to $357,640 from $108,106 in the prior year's quarter, leading to a net loss of $553,485 for the period, compared to a loss of $98,418 in the same period last year.
The company's primary focus is the development and demonstration of its QualOptima and QSurg software products, which leverage InterSystems technology to measure clinical performance and improve patient outcomes. Management plans to fund ongoing operations and development through additional equity or debt financing, acknowledging that such financing will likely result in dilution for existing shareholders. Without successful capital raising, the company may be forced to cease operations, leading to a complete loss of investment for shareholders.
02—Key points
Key Highlights
- The company continues to face substantial doubt about its ability to continue as a going concern, with a significant working capital deficit and a very low cash balance ($5,420 at July 31, 2012).
- Revenue for the three months ended July 31, 2012, was $9,000, a decrease from $10,800 in the same period of the prior year.
- Total operating expenses increased significantly to $357,640 from $108,106 in the prior year's quarter, primarily driven by higher software development and salary costs.
- The net loss for the quarter widened substantially to $553,485 from $98,418 in the prior year's quarter.
- The company is heavily reliant on future equity or debt financing to fund operations, with no assurance of success. Failure to secure financing could lead to cessation of operations.
- Significant related party transactions are noted, including amounts owed for software development, salaries, and rent, indicating potential conflicts of interest and financial dependencies.
- The company's disclosure controls and procedures were deemed not effective due to material weaknesses in internal control over financial reporting that remain unremediated.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2012filed September 19, 2012Financial Statements
Q3 FY2012 against Q3 FY2011
| Line item | Q3 FY2012Q3 FY2011 | Change |
|---|---|---|
| Revenue | $9K$11K | −16.7% |
| R&D Expenses | $162K$51K | +220.4% |
| Operating Income | -$349K-$156K | −123.1% |
| Interest Expense | -$82K-$1K | −7272.8% |
| Net Income | -$553K-$315K | −76.0% |
05—Questions
Frequently Asked Questions
What is the company's financial health and outlook for continuing operations?
Quture International, Inc. is in a precarious financial position. The company has a substantial working capital deficit and ended the quarter with only $5,420 in cash. Management explicitly states there is substantial doubt about the company's ability to continue as a going concern. Operations are dependent on securing additional financing through private placements or debt, with no guarantee of success. Failure to raise capital could lead to the cessation of business operations, resulting in a total loss for investors.
How is the company generating revenue, and what are its expenses?
Revenue for the three months ending July 31, 2012, was minimal at $9,000, down from $10,800 in the prior year. Operating expenses, however, more than tripled to $357,640 from $108,106 in the comparable prior-year period. This increase was primarily due to higher software development costs ($162,314 vs. $50,659) and increased salaries and benefits ($90,486 vs. $30,000).
What are the company's primary business activities and future plans?
Quture International is focused on developing and demonstrating medical software products (QualOptima and QSurg) that leverage InterSystems technology for clinical performance measurement and electronic medical records. They are conducting 'clinical trials' and demonstrations with hospitals, including the University of Miami, Miller School of Medicine, and Jackson Memorial Hospital. The go-to-market strategy involves partnerships with healthcare law and accounting firms and aims to secure contracts with reference hospitals, eventually targeting larger hospital systems. The commercialization of products is projected to follow successful demonstrations.
Are there any significant related party transactions or potential conflicts of interest?
Yes, the filing highlights several related party transactions. The company owes significant amounts to Q'Zure, LLC ($543,150 for software development and $19,321 in management fees), where Geoffrey Feazell, an officer, is the managing partner. Officers G. Landon Feazell and Barry Hollander have accrued unpaid salaries and advances. Additionally, the company previously leased office space from Sunset Quay Outfitters, LLC, controlled by Geoffrey Feazell. These transactions indicate potential financial dependencies and require careful scrutiny.
06—Continue